Safety of targeting ROR1 for cancer immunotherapy with chimeric antigen receptor-modified T cells in a primate model
S Carolina Berger, Daniel Sommermeyer, Michael Hudecek, Michael Berger, Ashwini Balakrishnan, Paulina Paskiewicz, Paula Kosasih, Christoph Rader, Stanley Riddell
Journal for ImmunoTherapy of Cancer Dec 2014, 2 (Suppl 3) P3; DOI: 10.1186/2051-1426-2-S3-P3